THE Therapeutic Goods Administration has confirmed a restructure of its advisory committees, which have been reduced from 11 to 7 effective 01 Jan 2017, as part of the response to the Expert Review of Medicines and Medical Devices Regulation.
A broader Advisory Committee on Medicines (ACM) replaces the former Advisory Committee on Prescription Medicines (ACPM), the Advisory Committee on Non-prescription medicines (ACNM) and the Advisory Committtee on the Safety of Medicines (ACSOM).
The Therapeutic Goods Committee (TGC) was abolished, while the Advisory Committee on Biologicals (ACB) and the Advisory Committee on Complementary Medicines (ACCM) continue with expanded functions.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Jan 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Jan 17
